Delivery Order SPE2DB20D9331-SPE2DB23FL1C8

Award Date 6/15/23
Potential Completion Date 7/10/23
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a Firm Fixed Price delivery order contract worth $4,437.90 issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract is for the supply of a pharmaceutical product, TESTOPEL 75 MG PELLETS 10S, to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,420.40, is for the delivery of TESTOPEL 75 MG PELLETS 10S medical supplies. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which runs through December 31, 2025. This IDC allows the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,768.16, is for the delivery of TESTOPEL 75 MG PELLETS 10S, a specialized pharmaceutical product, with a period of performance through February 13, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,430.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with an ultimate completion date of November 17, 2021, is for the supply of the drug TESTOPEL 75 MG PELLETS 10S. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB...
This federal contract award, valued at $4,420.40, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the provision of TESTOPEL 75 MG PELLETS 10S, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency for $4,420.40. The order is for the supply of TESTOPEL 75 MG PELLETS 10S to DLA Troop Support Medical facilities, with performance through December 2023. DMS Pharmaceutical Group holds this indefinite delivery contract with the Defense Logistics Agency to provide various pharmaceutical and medical supplies with a potential value of up to $5...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,420.40 firm fixed-price delivery order is for the supply of TESTOPEL 75 MG PELLETS 10S, a pharmaceutical product, with a period of performance through April 28, 2023. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,420.40, is to provide the DLA with the pharmaceutical product "TESTOPEL 75 MG PELLETS 10S". This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB...
This federal contract award, SPE2DB20D9331|SPE2DB23FL1H0, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,840.80 firm fixed-price delivery order is for the supply of TESTOPEL 75 MG PELLETS 10S, with an ultimate completion date of August 21, 2023. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,094.28 contract is for the delivery of a specialized pharmaceutical product, TESTOPEL 75MG PELL 10S, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers. This delivery order is part of a larger...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB23FL1C8
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The $4,420.40 contract is for the supply of TESTOPEL 75 MG PELLETS 10S, a pharmaceutical product, to the DLA.

DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The current award is one such delivery order under this larger IDC vehicle. DMS Pharmaceutical Group is a critical supplier in the federal pharmaceutical supply chain, providing both routine and specialized medications to support the diverse medical requirements of the Department of Defense.

Generated 1/9/25, 9:08 AM